Hans W. Sollinger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Hans W. Sollinger has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- John D. Pirsch
Division of Transplantation, University of Wisconsin, Madison, WI, USA
5 shared publications - Stuart J. Knechtle
Duke Transplant Center, Department of Surgery, Duke University Medical Center, Durham, NC 27710
4 shared publications Anthony M. D'Alessandro
From the Division of Transplantation, University of Wisconsin, Madison, WI
3 shared publicationsMunci Kalayoglu
3 shared publicationsAlam T
2 shared publicationsAnthony M D'alessandro
2 shared publications
Latest Publications
- Open Access
- 1 January 2020
- Published by Sci Forschen, Inc. in Journal of Diabetes Research and Therapy
- Vol. 6 (1)
Insulin Gene Therapy for Treating Type I Diabetes Mellitus: History, Progress and Future Challenges
Type 1 Diabetes Mellitus (T1DM) results from the autoimmune destruction of insulin-producing pancreatic β cells.
- 1 January 2020
- Published by Sci Forschen, Inc. in Journal of Diabetes Research and Therapy
- Vol. 6 (1)
Open AccessInsulin Gene Therapy for Treating Type I Diabetes Mellitus: History, Progress and Future Challenges
Type 1 Diabetes Mellitus (T1DM) results from the autoimmune destruction of insulin-producing pancreatic β cells.
- 1 September 2019
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 7 (5) , 739-741
Renal autotransplantation results in pain resolution after left renal vein transposition
- 1 September 2019
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 7 (5) , 739-741
Renal autotransplantation results in pain resolution after left renal vein transposition
- Open Access
- 5 March 2019
- Published by Elsevier in American Journal of Transplantation
- Vol. 19 (9) , 2543-2549
Enteric conversion after bladder-drained pancreas transplantation is not associated with worse allograft survival
- 5 March 2019
- Published by Elsevier in American Journal of Transplantation
- Vol. 19 (9) , 2543-2549
Open AccessEnteric conversion after bladder-drained pancreas transplantation is not associated with worse allograft survival
- Open Access
- 1 July 2017
- Published by Noble Research Publishers in Journal of Diabetology and Endocrinology
- Vol. 2 (1) , 1-10
Long-term correction of diabetic hyperglycemia through glucose-responsive hepatic insulin production using lentivirus
- 1 July 2017
- Published by Noble Research Publishers in Journal of Diabetology and Endocrinology
- Vol. 2 (1) , 1-10
Open AccessLong-term correction of diabetic hyperglycemia through glucose-responsive hepatic insulin production using lentivirus
- Open Access
- 18 May 2016
- Published by IntechOpen
Insulin Gene Therapy for Type 1 Diabetes Mellitus: Unique Challenges Require Innovative Solutions
Insulin Gene Therapy for Type 1 Diabetes Mellitus: Unique Challenges Require Innovative Solutions | InTechOpen, Published on: 2016-05-18. Authors: Andrew M Handorf, Hans W Sollinger and Tausif Alam
- 18 May 2016
- Published by IntechOpen
Open AccessInsulin Gene Therapy for Type 1 Diabetes Mellitus: Unique Challenges Require Innovative Solutions
Insulin Gene Therapy for Type 1 Diabetes Mellitus: Unique Challenges Require Innovative Solutions | InTechOpen, Published on: 2016-05-18. Authors: Andrew M Handorf, Hans W Sollinger and Tausif Alam
- 17 September 2015
- Published by Springer Nature
- p. 913-921
Pancreas Transplantation
- 1 April 2015
- p. 37-45
Insulin gene therapy for type 1 diabetes mellitus.
Type 1 diabetes mellitus is an autoimmune disease resulting from the destruction of pancreatic β cells. Current treatments for patients with type 1 diabetes mellitus include daily insulin injections or whole pancreas transplant, each of which are associated with profound drawbacks. Insulin gene therapy, which has shown great efficacy in correcting hyperglycemia in animal models, holds great promise as an alternative strategy to treat type 1 diabetes mellitus in humans. Insulin gene therapy refers to the targeted expression of insulin in non-β cells, with hepatocytes emerging as the primary therapeutic target. In this review, we present an overview of the current state of insulin gene therapy to treat type 1 diabetes mellitus, including the need for an alternative therapy, important features dictating the success of the therapy, and current obstacles preventing the translation of this treatment option to a clinical setting. In so doing, we hope to shed light on insulin gene therapy as a viable option to treat type 1 diabetes mellitus.
- 1 April 2015
- p. 37-45
Insulin gene therapy for type 1 diabetes mellitus.
Type 1 diabetes mellitus is an autoimmune disease resulting from the destruction of pancreatic β cells. Current treatments for patients with type 1 diabetes mellitus include daily insulin injections or whole pancreas transplant, each of which are associated with profound drawbacks. Insulin gene therapy, which has shown great efficacy in correcting hyperglycemia in animal models, holds great promise as an alternative strategy to treat type 1 diabetes mellitus in humans. Insulin gene therapy refers to the targeted expression of insulin in non-β cells, with hepatocytes emerging as the primary therapeutic target. In this review, we present an overview of the current state of insulin gene therapy to treat type 1 diabetes mellitus, including the need for an alternative therapy, important features dictating the success of the therapy, and current obstacles preventing the translation of this treatment option to a clinical setting. In so doing, we hope to shed light on insulin gene therapy as a viable option to treat type 1 diabetes mellitus.
- 1 September 2014
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 64 (3) , 460-472
Loin Pain Hematuria Syndrome
- 1 September 2014
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 64 (3) , 460-472
Loin Pain Hematuria Syndrome
- 15 January 2013
- Published by Wolters Kluwer Health in Transplantation
- Vol. 95 (1) , 8-14
The Medawar Prize 2012, Dr David Sutherland
- 15 January 2013
- Published by Wolters Kluwer Health in Transplantation
- Vol. 95 (1) , 8-14
The Medawar Prize 2012, Dr David Sutherland
- Open Access
- 18 December 2011
- Published by Brieflands in Nephro-Urology Monthly
- Vol. 4 (1) , 399-400
Favorable Outcomes After Renal Transplantation in Patients With Diabetes Mellitus
Favorable Outcomes After Renal Transplantation in Patients With Diabetes Mellitus - Nephro-Urology Monthly - 2011 - Kowsar
- 18 December 2011
- Published by Brieflands in Nephro-Urology Monthly
- Vol. 4 (1) , 399-400
Open AccessFavorable Outcomes After Renal Transplantation in Patients With Diabetes Mellitus
Favorable Outcomes After Renal Transplantation in Patients With Diabetes Mellitus - Nephro-Urology Monthly - 2011 - Kowsar